In the BioHarmony Drug Report Database

"Preview" Icon

Triheptanoin

Dojolvi (triheptanoin) is a small molecule pharmaceutical. Triheptanoin was first approved as Dojolvi on 2020-06-30. Dojolvi’s patent is valid until 2025-10-03 (FDA).

 

Trade Name

 

Dojolvi
 

Common Name

 

triheptanoin
 

ChEMBL ID

 

CHEMBL4297585
 

Indication

 

 

Drug Class

 

Glycerolipids

Image (chem structure or protein)

Triheptanoin structure rendering